Di Perri G - Search Results

1

Efficacy, tolerability and virological consequences of long-term use of unboosted atazanavir plus 2 NRTIs in HIV-infected patients.

Bonora S, Calcagno A, Vigano O, Bigliano P, Marinaro L, Colella E, Orofino G, Trentini L, Tettoni MC, D'Avolio A, Mercadante S, Galli M, Di Perri G, Rusconi S. Bonora S, et al. Among authors: di perri g. Curr HIV Res. 2014;12(5):339-46. doi: 10.2174/1570162x12666140807151616. Curr HIV Res. 2014. PMID: 25106410

2

Tenofovir plasma concentrations according to companion drugs: a cross-sectional study of HIV-positive patients with normal renal function.

Calcagno A, Gonzalez de Requena D, Simiele M, D'Avolio A, Tettoni MC, Salassa B, Orofino G, Bramato C, Libanore V, Motta I, Bigliano P, Orsucci E, Di Perri G, Bonora S. Calcagno A, et al. Among authors: di perri g. Antimicrob Agents Chemother. 2013 Apr;57(4):1840-3. doi: 10.1128/AAC.02434-12. Epub 2013 Feb 4. Antimicrob Agents Chemother. 2013. PMID: 23380733 Free PMC article.

3

Etravirine plasma exposure is associated with virological efficacy in treatment-experienced HIV-positive patients.

Calcagno A, Marinaro L, Nozza S, Aldieri C, Carbone A, Ghisetti V, Trentalange A, D'Avolio A, Castagna A, Di Perri G, Bonora S. Calcagno A, et al. Among authors: di perri g. Antiviral Res. 2014 Aug;108:44-7. doi: 10.1016/j.antiviral.2014.05.009. Epub 2014 May 23. Antiviral Res. 2014. PMID: 24861522 Free article.

4

Successful pharmacogenetics-based optimization of unboosted atazanavir plasma exposure in HIV-positive patients: a randomized, controlled, pilot study (the REYAGEN study).

Bonora S, Rusconi S, Calcagno A, Bracchi M, Viganò O, Cusato J, Lanzafame M, Trentalange A, Marinaro L, Siccardi M, D'Avolio A, Galli M, Di Perri G. Bonora S, et al. Among authors: di perri g. J Antimicrob Chemother. 2015 Nov;70(11):3096-9. doi: 10.1093/jac/dkv208. Epub 2015 Jul 14. J Antimicrob Chemother. 2015. PMID: 26174719 Free article. Clinical Trial.

5

Therapeutic drug monitoring of boosted PIs in HIV-positive patients: undetectable plasma concentrations and risk of virological failure.

Calcagno A, Pagani N, Ariaudo A, Arduino G, Carcieri C, D'Avolio A, Marinaro L, Tettoni MC, Trentini L, Di Perri G, Bonora S. Calcagno A, et al. Among authors: di perri g. J Antimicrob Chemother. 2017 Jun 1;72(6):1741-1744. doi: 10.1093/jac/dkx052. J Antimicrob Chemother. 2017. PMID: 28333285

6

[Clinical pharmacology of nucleoside and nucleotide reverse transcriptase inhibitors].

Bonora S, Calcagno A, Gonzalez de Requena D, Bargiacchi O, Di Perri G. Bonora S, et al. Among authors: di perri g. Infez Med. 2006 Jun;14(2):61-70. Infez Med. 2006. PMID: 16891850 Free article. Review. Italian.

7

Antiretroviral activity of pegylated interferon alfa-2a in patients co-infected with HIV/hepatitis C virus.

Aguilar Marucco D, Veronese L, de Requena DG, Bonora S, Calcagno A, Cavecchia I, Sinicco A, De Rosa FG, Cariti G, Di Perri G. Aguilar Marucco D, et al. Among authors: di perri g. J Antimicrob Chemother. 2007 Mar;59(3):565-8. doi: 10.1093/jac/dkl497. Epub 2007 Jan 9. J Antimicrob Chemother. 2007. PMID: 17213263

8

Moxifloxacin for the treatment of HIV-associated tuberculosis in patients with contraindications or intolerance to rifamycins.

Bonora S, Mondo A, Trentini L, Calcagno A, Lucchini A, Di Perri G. Bonora S, et al. Among authors: di perri g. J Infect. 2008 Jul;57(1):78-81. doi: 10.1016/j.jinf.2008.05.005. Epub 2008 Jun 11. J Infect. 2008. PMID: 18550175

9

Short-term additional enfuvirtide therapy is associated with a greater immunological recovery in HIV very late presenters: a controlled pilot study.

Bonora S, Calcagno A, Cometto C, Fontana S, Aguilar D, D'Avolio A, Gonzalez de Requena D, Maiello A, Dal Conte I, Lucchini A, Di Perri G. Bonora S, et al. Among authors: di perri g. Infection. 2012 Feb;40(1):69-75. doi: 10.1007/s15010-011-0223-4. Epub 2011 Dec 2. Infection. 2012. PMID: 22135137 Clinical Trial.

10

Seminal pharmacokinetics and antiviral efficacy of once-daily maraviroc plus lopinavir/ritonavir in HIV-infected patients.

Calcagno A, Nozza S, Simiele M, Milia MG, Chiappetta S, D'Avolio A, Ghisetti V, Lazzarin A, Di Perri G, Bonora S. Calcagno A, et al. Among authors: di perri g. J Antimicrob Chemother. 2014 Sep;69(9):2586-8. doi: 10.1093/jac/dku142. Epub 2014 May 8. J Antimicrob Chemother. 2014. PMID: 24812593 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

728 results

Search Page

Filters